Systematic reviews on corona disease 2019 (COVID-19)
COVID-19 (coronavirus disease 2019) is a public health emergency of international concern. As of this time, there is very limited data available on almost all aspects of this disease.
We are refocussing our work to provide rapid systematic reviews on COVID-19. In the first place we will focus on risk factors for prognosis, risk factors for incidence and the effectiveness of new interventions.
We are looking for colleagues with experience in systematic reviews to help us, specifically those with expertise literature searching of pre-print journals and archives, critical appraisal and meta-analyses in stata.
If you are interested please contact m.zeegers@maastrichtuniversity.nl
Also read
-
UM to play a more prominent role in Dutch scientific infrastructure
Eleven consortia from various scientific disciplines are set to launch projects of great value to science. The Dutch government is making a total of €197 million available for this purpose. Scientists from Maastricht University (UM) are closely involved in seven of the eleven projects.
-
17 million for Dutch mega cohort: working together to build healthier ageing
MUMC+ is main applicant in the NCC: a unique research infrastructure with data from almost half a million Dutch citizens.
-
Letting bone and cartilage repair themselves
Tim ten Brink focuses on developing implants for damaged bone and cartilage, so eventually there is less need for invasive surgery.
